Author :
Abstract
Hastaneye başvuran hastaların yoğun bakım ihtiyaçları ve yoğun bakımlarda ex olan hasta oranları hizmet alınan sağlık kurumuna göre farklılıklar gösterebilir. Dünyada; ülke bazlı hatta sağlık kurum bazlı yoğun bakım ihtiyacı ile yoğun bakımlarda ex ve iyileşme oranları değişmektedir. Amaç: Kendi kurumumuzda yoğun bakım yatış ve yoğun bakım ex oranlarını belirlemektir. Gereç yöntem: Mart-Aralık ayları arasında COVİD 19 yoğun bakım ve COVİD 19 servislerinde PCR pozitif yatarak tedavi alan hastalar retrospektif olarak taranmıştır Verilerin analizi SPSS 25 programı ile yapılmış ve %95 güven düzeyi ile çalışılmıştır. Bulgular: Hastanemizde 9 aylık süreçte yatan hastaların %11’i yoğun bakıma yatmış ve yoğun bakıma yatanların %47’si ex olmuştur. Ex gün sayısı %40 hasta da ve ilk 2 günde gerçekleşmiştir. Sonuç: Tüm dünya ülkelerinde COVİD 19 takip ve tadavi farklılıkları gerek yoğun bakım gerekse normal servislerdeki morbidite ve mortalite ve iyileşme oranlarını da farklılaştırmıştır. Virüsün mutasyonu ile bu durum daha karmaşık hale gelmiştir.
Keywords
Abstract
The intensive care needs of the patients admitted to the hospital and the rate of patients who die in intensive care units may differ according to the healthcare institution from which service is received. In the world, the need for intensive care and mortality and recovery rates in intensive care units vary on the basis of country and even health institution. Aim: The purpose of the study was to determine the hospitalization in the intensive care unit and intensive care mortality rates in our own institution. Materials and methods: The patients who were admitted between March and December and received treatment in the PCR positive intensive care unit were retrospectively screened. Data analysis was performed with the SPSS 25 program, and the study was conducted with 95% confidence level. Result: 11% of the patients hospitalized in our hospital in the 9-month period were hospitalized in the intensive care unit, and 47% of the patients in the intensive care unit died. Mortality occurred in 40% patients in the first 2 days of hospitalization in the intensive care unit. Conclusion COVİD 19 follow-up and treatment differences in all countries of the world have also differentiated the morbidity and mortality and recovery rates in both intensive care and normal services. This situation has become more complicated with the mutation of the virus.
Keywords
- 1. Xu X, Ong Y, & Wang D,at all. Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines. Military Medical Research Volume 2020; 7 (1) 22-22.
- 2. TCSBHSG COVID-19 SARS-CoV-2 Infection Guideline. Scientific Committee Study. 2020
- 3. Gosch M. Singler K, and Kwetkat A at all. Geriatrics in times of corona. 2020; 228-232, Vol 53 (3).
- 4. Remuzzi A. and Remuzzi G. COVID-19 and Italy: what next. London, 2020;395, 1225-1228,
- 5. Griselli G. Zangrillo a. Zanella A. Antonelli M. Main Characteristics and Results of 1,591 Patients Infected with SARS-CoV-2 Admitted to ICUs in the Lombardy Region, Italy'28; 323 (16): 15741581.doi: 10,1001 / jama.2020,5394.
- 6. Xiaobo yang, Yuan Yu, Jiqian xu, Huaqing Shu. Clinical course and results of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single center, retrospective, observational study. 2020; 8 (5): 475-481. doi: 10,1016
- 7. Sara C, Mark Caridi-Scheible, James M. Blum at all Intensive Care and Ventilator Deaths in Critically Ill Adults with Coronavirus Disease Crit Care Med. 26 May 2020; 10,1097 / CCM.000.000.004.457.
- 8. Udit Chaddha, Viren Kaul, and Abhinav Agrawal. What is the True Mortality in Critical Patients with COVID-19?'Indian J Crit Care Med. 2020; 24 (6): 383--384.doi: 10,5005 / jp-journals-10071-23435
- 9. Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R. et all. Clinical features of COVID-19 in New York' N Engl J Med. 2020;doi: 10,1056 / NEJMc2010419.
- 10. Zhou F, Yu T, Du R, Fan G. et al. Clinical course and risk factors for mortality among inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395,10229 1054-1062. doi: 10,1016 / S0140-6736 (20) 30566-3.
